AFJK

About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

CEO: Junheng Xie
IPO Date: Jan 22, 2024

Market Data

Volume: 607

Valuation

Market Cap: $247M

Financials

Financial statement snapshot is not available yet.